Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cluster-randomized Trial of Low Molecular Weight Heparins - Directly Through EPIC

NCT06020560 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT06020560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06020560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cluster-randomized Trial of Low Molecular Weight Heparins - Directly Through EPIC
Lead sponsor
Herlev Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 23, 2023
Completion date
March 23, 2025
Enrollment
65,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant, prophylaxis, treatment, venous thromboembolism